Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F3EC2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,904
Award facts
- Contract value 100% obligated
- $29,904.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication, under a firm fixed price contract valued at $29,904.48. The award was made on November 25, 2025, with an ultimate completion date of November 26, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems. The company has demonstrated significant capability in fulfilling federal medical supply needs through multiple competitive awards involving various therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The placement of performance at the company's Conshohocken facility reflects its operational capacity to support the Defense Health Agency and other government healthcare systems through the flexible and comprehensive contract vehicle established by the DLA.
Quick answers
Who was awarded contract SPE2DR26F3EC2?
SPE2DR26F3EC2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F3EC2 worth?
The government has obligated $29,904 on SPE2DR26F3EC2.
Is contract SPE2DR26F3EC2 an order under another contract?
Yes. SPE2DR26F3EC2 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3EC2 competed?
The extent of competition for SPE2DR26F3EC2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award